The underlying mechanism has been linked to the STK11 genetic alteration, resulting in an indolent, immunosuppressive tumour milieu, characterised by lower infiltration of TILs, reduced expression of inflammatory cytokines, and epigenetic inhibition of the stimulator of IFN genes (STING). Here, STK11 is linked to neoplasm.